• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

磁共振成像在前列腺癌中的现状

The current status of MRI in 
prostate cancer.

作者信息

Pedler Kesley, Kitzing Yu Xuan, Varol Celi, Arianayagam Mohan

机构信息

MBBS FRACS (Urol), Urology Fellow, Nepean Hospital, Kingswood, NSW.

出版信息

Aust Fam Physician. 2015 Apr;44(4):225-30.

PMID:25901408
Abstract

BACKGROUND

The diagnosis and treatment of prostate cancer is a controversial topic. Until recently there has not been a reliable imaging mo-dality for identification of cancer within the prostate. New evidence suggests that multiparametric magngenetic resonance im-aging (MRI) has the potential to improve the diagnosis and treatment of prostate cancer.

OBJECTIVE

This article explains the potential roles for multiparametric MRI in the diagnosis and treatment of prostate cancer.

DISCUSSION

Multiparametric MRI can help identify regions which may represent clinically significant prostate cancer. MRI may also be used to guide varying prostate cancer treatment modalities. An experienced radiologist and adequately powered MRI scanner are es-sential. Multiparametric MRI in the hands of an experienced uroradiology team is emerging as a useful tool in the diagnosis and treatment of prostate cancer however this technology is still in its infancy and requires further evaluation. At this time prostate MRI should only be ordered by the treating urologist.

摘要

背景

前列腺癌的诊断与治疗是一个存在争议的话题。直到最近,还没有一种可靠的成像方式用于识别前列腺内的癌症。新证据表明,多参数磁共振成像(MRI)有潜力改善前列腺癌的诊断与治疗。

目的

本文解释多参数MRI在前列腺癌诊断与治疗中的潜在作用。

讨论

多参数MRI有助于识别可能代表具有临床意义的前列腺癌的区域。MRI也可用于指导不同的前列腺癌治疗方式。经验丰富的放射科医生和功率足够的MRI扫描仪至关重要。在经验丰富的泌尿放射学团队手中,多参数MRI正成为前列腺癌诊断与治疗中的一种有用工具,然而这项技术仍处于起步阶段,需要进一步评估。目前,前列腺MRI仅应由主治泌尿科医生开具检查单。

相似文献

1
The current status of MRI in 
prostate cancer.磁共振成像在前列腺癌中的现状
Aust Fam Physician. 2015 Apr;44(4):225-30.
2
Multiparametric magnetic resonance imaging in the detection of prostate cancer.多参数磁共振成像在前列腺癌检测中的应用
Aktuelle Urol. 2014 Mar;45(2):119-26. doi: 10.1055/s-0034-1371875. Epub 2014 Apr 3.
3
Multiparametric magnetic resonance imaging of the prostate can improve the predictive value of the urinary prostate cancer antigen 3 test in patients with elevated prostate-specific antigen levels and a previous negative biopsy.前列腺多参数磁共振成像可以提高前列腺特异性抗原水平升高且既往前列腺活检阴性患者的尿前列腺癌抗原 3 检测的预测价值。
BJU Int. 2012 Dec;110(11):1661-5. doi: 10.1111/j.1464-410X.2012.11146.x. Epub 2012 May 4.
4
Current role of multiparametric magnetic resonance imaging in the management of prostate cancer.多参数磁共振成像在前列腺癌管理中的当前作用。
Korean J Urol. 2015 May;56(5):337-45. doi: 10.4111/kju.2015.56.5.337. Epub 2015 Apr 6.
5
Interpretation and reporting multiparametric prostate MRI: a primer for residents and novices.多参数前列腺MRI的解读与报告:住院医师和新手入门指南
Abdom Imaging. 2014 Oct;39(5):1036-51. doi: 10.1007/s00261-014-0097-x.
6
MR imaging of the prostate.前列腺的磁共振成像
Radiol Clin North Am. 2014 Jul;52(4):811-37. doi: 10.1016/j.rcl.2014.02.010. Epub 2014 Apr 2.
7
Prostate magnetic resonance imaging: challenges of implementation.前列腺磁共振成像:实施过程中的挑战
Curr Probl Diagn Radiol. 2015 Jan-Feb;44(1):26-37. doi: 10.1067/j.cpradiol.2014.05.009. Epub 2014 Jul 26.
8
Overview of current multiparametric magnetic resonance imaging approach in the diagnosis and staging of prostate cancer.当前多参数磁共振成像方法在前列腺癌诊断和分期中的概述。
Kaohsiung J Med Sci. 2015 Apr;31(4):167-78. doi: 10.1016/j.kjms.2015.01.002. Epub 2015 Feb 17.
9
Multiparametric magnetic resonance imaging in the detection of prostate cancer.多参数磁共振成像在前列腺癌检测中的应用
Rofo. 2014 Mar;186(3):238-46. doi: 10.1055/s-0034-1365937. Epub 2014 Jan 22.
10
Prostate cancer: top places where tumors hide on multiparametric MRI.前列腺癌:多参数磁共振成像中肿瘤隐匿的主要部位。
AJR Am J Roentgenol. 2015 Apr;204(4):W449-56. doi: 10.2214/AJR.14.13280.

引用本文的文献

1
Clinical value of prostate health index as an indicator for recommending magnetic resonance imaging in patients with gray-zone prostate-specific antigen level.前列腺健康指数作为灰区前列腺特异抗原水平患者推荐磁共振成像指标的临床价值。
World J Urol. 2023 Dec;41(12):3519-3526. doi: 10.1007/s00345-023-04613-7. Epub 2023 Oct 4.
2
Radiomics for Identification and Prediction in Metastatic Prostate Cancer: A Review of Studies.用于转移性前列腺癌识别与预测的影像组学:研究综述
Front Oncol. 2021 Nov 1;11:771787. doi: 10.3389/fonc.2021.771787. eCollection 2021.
3
Clinical utility of a serum biomarker panel in distinguishing prostate cancer from benign prostate hyperplasia.
血清生物标志物联合检测在鉴别前列腺癌与前列腺增生中的临床应用价值。
Sci Rep. 2021 Jul 23;11(1):15052. doi: 10.1038/s41598-021-94438-4.
4
Improving the detection rate of prostate cancer in the gray zone of PI-RADS v2 and serum tPSA by using prostate-specific antigen-age volume.利用前列腺特异性抗原-年龄体积提高PI-RADS v2灰色区域及血清总前列腺特异性抗原中前列腺癌的检出率。
Medicine (Baltimore). 2019 Jun;98(26):e16289. doi: 10.1097/MD.0000000000016289.
5
In Vivo 3D MRI Measurement of Tumour Volume in an Orthotopic Mouse Model of Prostate Cancer.在前列腺癌原位模型小鼠中进行肿瘤体积的活体 3D MRI 测量。
Cancer Control. 2019 Jan-Dec;26(1):1073274819846590. doi: 10.1177/1073274819846590.
6
A retrospective analysis of Victorian and South Australian clinical registries for prostate cancer: trends in clinical presentation and management of the disease.对维多利亚州和南澳大利亚州前列腺癌临床登记处的回顾性分析:疾病临床表现和管理的趋势
BMC Cancer. 2016 Aug 5;16:607. doi: 10.1186/s12885-016-2655-9.